1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Synthetic Biology Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Synthetic Biology Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Synthetic Biology Market Regional Analysis
6.2 Europe Synthetic Biology Market Revenue 2019-2028 (US$ Million)
6.3 Europe Synthetic Biology Market Forecast Analysis
7. Europe Synthetic Biology Market Analysis – by Products
7.1 Enzymes
- 7.1.1 Overview
- 7.1.2 Enzymes: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Chassis Organisms
- 7.2.1 Overview
- 7.2.2 Chassis Organisms: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Oligonucleotides
- 7.3.1 Overview
- 7.3.2 Oligonucleotides: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Xeno-Nucleic Acids
- 7.4.1 Overview
- 7.4.2 Xeno-Nucleic Acids: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Synthetic Biology Market Analysis – by Technology
8.1 Measurement & Modeling
- 8.1.1 Overview
- 8.1.2 Measurement & Modeling: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Cloning & Sequencing
- 8.2.1 Overview
- 8.2.2 Cloning & Sequencing: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Genome Engineering
- 8.3.1 Overview
- 8.3.2 Genome Engineering: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Gene Synthesis
- 8.4.1 Overview
- 8.4.2 Gene Synthesis: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Nanotechnology
- 8.5.1 Overview
- 8.5.2 Nanotechnology: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Synthetic Biology Market Analysis – by Application
9.1 Medical Applications
- 9.1.1 Overview
- 9.1.2 Medical Applications: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Industrial Applications
- 9.2.1 Overview
- 9.2.2 Industrial Applications: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Food and Agriculture
- 9.3.1 Overview
- 9.3.2 Food and Agriculture: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Environmental Applications
- 9.4.1 Overview
- 9.4.2 Environmental Applications: Europe Synthetic Biology Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Synthetic Biology Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Synthetic Biology Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 Europe Synthetic Biology Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Synthetic Biology Market Breakdown, by Products
- 10.2.1.1.2 UK: Europe Synthetic Biology Market Breakdown, by Technology
- 10.2.1.1.3 UK: Europe Synthetic Biology Market Breakdown, by Application
- 10.2.1.2 Germany:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Synthetic Biology Market Breakdown, by Products
- 10.2.1.2.2 Germany: Europe Synthetic Biology Market Breakdown, by Technology
- 10.2.1.2.3 Germany: Europe Synthetic Biology Market Breakdown, by Application
- 10.2.1.3 France:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Synthetic Biology Market Breakdown, by Products
- 10.2.1.3.2 France: Europe Synthetic Biology Market Breakdown, by Technology
- 10.2.1.3.3 France: Europe Synthetic Biology Market Breakdown, by Application
- 10.2.1.4 Russia:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Synthetic Biology Market Breakdown, by Products
- 10.2.1.4.2 Russia: Europe Synthetic Biology Market Breakdown, by Technology
- 10.2.1.4.3 Russia: Europe Synthetic Biology Market Breakdown, by Application
- 10.2.1.5 Italy:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Synthetic Biology Market Breakdown, by Products
- 10.2.1.5.2 Italy: Europe Synthetic Biology Market Breakdown, by Technology
- 10.2.1.5.3 Italy: Europe Synthetic Biology Market Breakdown, by Application
- 10.2.1.6 Rest of Europe:
Europe Synthetic Biology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Synthetic Biology Market Breakdown, by Products
- 10.2.1.6.2 Rest of Europe: Europe Synthetic Biology Market Breakdown, by Technology
- 10.2.1.6.3 Rest of Europe: Europe Synthetic Biology Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Agilent Technologies, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Amyris
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Codexis
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Genscript Biotech corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Integrated DNA Technologies
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck KGaA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 New England Biolabs
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Novozymes A/S
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Thermo Fisher Scientific
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Twist Bioscience
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations